Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Korngold

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Cellular Immunology|April 1, 1985
Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferonK L Fresa, R Korngold, D M Murasko
Immunological Reviews|June 1, 1997
Recent advances in graft-versus-host disease (GVHD) preventionB R Blazar, R Korngold, D A Vallera
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virusR Korngold, K J Blank, D M Murasko
Immunological Reviews|June 1, 1986
Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivoJ Sprent, M Schaefer, D Lo, et al.
Immunology Today|October 24, 1998
CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug designS Li, T Satoh, R Korngold, et al.
Transplantation|August 1, 1993
The effect of graft-versus-host disease in response to minor histocompatibility antigens on acute murine cytomegalovirus infectionJ D Shanley, R Korngold, S J Forman
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1998
A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrierU Koch, S Choksi, L Marcucci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1998
Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host diseaseT M Friedman, M Gilbert, C Briggs, et al.
The American Journal of Pathology|April 1, 1991
Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cellsG F Murphy, D Whitaker, J Sprent, et al.
The Journal of Experimental Medicine|February 1, 1988
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hostsJ Sprent, M Schaefer, E K Gao, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Cellular Immunology|April 1, 1985
Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferonK L Fresa, R Korngold, D M Murasko
Immunological Reviews|June 1, 1997
Recent advances in graft-versus-host disease (GVHD) preventionB R Blazar, R Korngold, D A Vallera
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1983
Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virusR Korngold, K J Blank, D M Murasko
Immunological Reviews|June 1, 1986
Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivoJ Sprent, M Schaefer, D Lo, et al.
Immunology Today|October 24, 1998
CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug designS Li, T Satoh, R Korngold, et al.
Transplantation|August 1, 1993
The effect of graft-versus-host disease in response to minor histocompatibility antigens on acute murine cytomegalovirus infectionJ D Shanley, R Korngold, S J Forman
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1998
A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrierU Koch, S Choksi, L Marcucci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1998
Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host diseaseT M Friedman, M Gilbert, C Briggs, et al.
The American Journal of Pathology|April 1, 1991
Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cellsG F Murphy, D Whitaker, J Sprent, et al.
The Journal of Experimental Medicine|February 1, 1988
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hostsJ Sprent, M Schaefer, E K Gao, et al.
Pageof 10